This correlates with the immunosuppressive activity induced by M2 macrophages in advanced stages of the neoplastic process and immunomodulation exerted by tumor cells and tumor-associated stromal cells through cytokines as TGF-β and IL-10 as well as surface receptors like PD-L119,41,44. The gene discussed is TGFB1; the disease is neoplasm.